Editorial: High qHBsAg-is it a good or bad signal?

Beom Kyung Kim^{1

2

3}

Affiliations

¹ Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
² Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.

Editorial

Beom Kyung Kim. Aliment Pharmacol Ther. 2024 Jun.

. 2024 Jun;59(12):1616-1617.

doi: 10.1111/apt.17965. Epub 2024 Apr 21.

Beom Kyung Kim^{1

2

3}

¹ Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
² Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.

No abstract available

Comment in

Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply.
Lin HC, Jeng WJ, Yang HI. Lin HC, et al. Aliment Pharmacol Ther. 2024 Jun;59(12):1618-1619. doi: 10.1111/apt.18021. Epub 2024 May 7. Aliment Pharmacol Ther. 2024. PMID: 38715258 No abstract available.

Rapid Decline Rather Than Absolute Level of HBsAg Predicts Its Seroclearance in Untreated Chronic Hepatitis B Patients From Taiwanese Communities.
Lin HC, Liu J, Pan MH, Lee MH, Batrla-Utermann R, Lu SN, Jeng WJ, Yang HI, Chen CJ. Lin HC, et al. Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00586. doi: 10.14309/ctg.0000000000000586. Clin Transl Gastroenterol. 2023. PMID: 36988242 Free PMC article.

1. Mak LY, Hui RW, Fung J, Seto WK, Yuen MF. The role of different viral biomarkers on the management of chronic hepatitis B. Clin Mol Hepatol. 2023;29:263–276.
1. Zhang H, Tu T. Approaches to quantifying hepatitis B virus covalently closed circular DNA. Clin Mol Hepatol. 2022;28:135–149.
1. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142:1140–1149.e3.
1. Kawanaka M, Nishino K, Nakamura J, Oka T, Urata N, Goto D, et al. Quantitative levels of hepatitis B virus DNA and surface antigen and the risk of hepatocellular carcinoma in patients with hepatitis B receiving long‐term nucleos(t)ide analogue therapy. Liver Cancer. 2014;3:41–52.
1. Lin HC, Liu J, Pan MH, Lee MH, Batrla‐Utermann R, Lu SN, et al. Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities. Clin Transl Gastroenterol. 2023;14:e00586.